Procter & Gamble NewsMore News
InvestorPlace
3 Places to Hide if You Think Inflation Is Going to Continue to Roar
InvestorPlace
The Top 7 Dividend Stocks to Buy in March 2024
InvestorPlace
Secure Your Future: 7 Dividend Kings with Solid Growth Potential
Benzinga
InvestorPlace
Safe Haven Stocks: 3 Non-Cyclical Picks to Protect Your Portfolio
Historical Prices for Procter & Gamble
| Date | Open | Close | Daily High | Daily Low |
|---|
Price change over selected period:0%0
Procter & Gamble Analyst Data
Total Analysts: 75
Buy Ratings: 63 Neutral Ratings: 12 Sell Ratings: 0
Analyst: {{ANALYST_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price *Price Target
Lowest: 130.00 Median: 163.43 Highest: 180.00
*The average price target includes all analyst analysis, not just the most recent analysis presented in the chart.
Procter & Gamble Analyst Opinions
- All
- Buy
- Hold
- Sell
| Date | Analyst | Rating | Price | |||
|---|---|---|---|---|---|---|
| 03/01/24 | Goldman Sachs | Maintained Hold | $168 | neutral | ||
| 01/25/24 | Barclays Capital | Maintained Buy | $165 | gut | ||
| 01/24/24 | RBC Capital Markets | Maintained Hold | $157 | neutral | ||
| 01/24/24 | Stifel, Nicolaus & Co., Inc. | Maintained Buy | $157 | gut | ||
| 01/24/24 | UBS | Maintained Buy | $178 | gut | ||
| 01/24/24 | Wells Fargo & Co | Maintained Buy | $170 | gut | ||
| 01/24/24 | Raymond James Financial, Inc. | Maintained Buy | $175 | gut | ||
| 01/18/24 | J.P. Morgan | Maintained Buy | $162 | gut | ||
| 01/16/24 | Barclays Capital | Maintained Buy | $160 | gut | ||
| 11/13/23 | Jefferies & Company Inc. | Maintained Buy | $177 | gut | ||
| 10/20/23 | DZ BANK | Upgraded to Buy | $155 | gut | ||
| 10/19/23 | Wells Fargo & Co | Maintained Buy | $162 | gut | ||
| 10/19/23 | Stifel, Nicolaus & Co., Inc. | Maintained Buy | $155 | gut | ||
| 10/16/23 | Stifel, Nicolaus & Co., Inc. | Maintained Buy | $151 | gut | ||
| 10/12/23 | Barclays Capital | Maintained Buy | $154 | gut | ||
| 10/12/23 | J.P. Morgan | Maintained Buy | $169 | gut | ||
| 10/12/23 | Bernstein | Maintained Hold | $153 | neutral | ||
| 09/22/23 | HSBC | Maintained Buy | $179 | gut | ||
| 09/08/23 | William Blair | Maintained Hold | neutral | |||
| 08/01/23 | Morgan Stanley | Maintained Buy | $174 | gut | ||
| 08/01/23 | Bank of America Merrill Lynch | Maintained Buy | $175 | gut | ||
| 08/01/23 | Barclays Capital | Maintained Buy | $166 | gut | ||
| 07/31/23 | RBC Capital Markets | Maintained Hold | $167 | neutral | ||
| 07/31/23 | Wells Fargo & Co | Maintained Buy | $170 | gut | ||
| 07/31/23 | Deutsche Bank | Maintained Buy | $173 | gut | ||
| 07/25/23 | Morgan Stanley | Maintained Buy | $174 | gut | ||
| 07/20/23 | Barclays Capital | Maintained Buy | $160 | gut | ||
| 07/11/23 | Citigroup Corp. | Maintained Buy | $177 | gut | ||
| 04/26/23 | Barclays Capital | Maintained Buy | $167 | gut | ||
| 04/24/23 | Citigroup Corp. | Maintained Buy | $177 | gut | ||
| 04/24/23 | Evercore | Maintained Buy | $170 | gut | ||
| 04/24/23 | Jefferies & Company Inc. | Maintained Buy | $175 | gut | ||
| 04/24/23 | Raymond James Financial, Inc. | Maintained Buy | $175 | gut | ||
| 04/24/23 | RBC Capital Markets | Maintained Hold | $165 | neutral | ||
| 04/24/23 | Morgan Stanley | Maintained Buy | $174 | gut | ||
| 04/24/23 | UBS | Maintained Buy | $180 | gut | ||
| 04/14/23 | Barclays Capital | Maintained Buy | $160 | gut | ||
| 04/06/23 | UBS | Maintained Buy | $170 | gut | ||
| 03/20/23 | Deutsche Bank | Maintained Buy | $156 | gut | ||
| 03/03/23 | J.P. Morgan | Upgraded to Buy | $155 | gut | ||
| 03/01/23 | UBS | Upgraded to Buy | $163 | gut | ||
| 02/17/23 | Citigroup Corp. | Maintained Buy | $160 | gut | ||
| 01/23/23 | Barclays Capital | Maintained Buy | $158 | gut | ||
| 01/20/23 | Stifel, Nicolaus & Co., Inc. | Maintained Buy | $147 | gut | ||
| 01/20/23 | Wells Fargo & Co | Maintained Buy | $162 | gut | ||
| 01/13/23 | J.P. Morgan | Maintained Hold | $150 | neutral | ||
| 01/13/23 | Raymond James Financial, Inc. | Maintained Buy | $170 | gut | ||
| 01/03/23 | Wells Fargo & Co | Maintained Buy | $168 | gut | ||
| 12/06/22 | Deutsche Bank | Maintained Buy | $162 | gut | ||
| 11/22/22 | Wolfe Research | Maintained Buy | $156 | gut |
Procter & Gamble Estimates* in USD
| 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|
| Revenue | 84,814 | 88,057 | 91,856 | 96,196 | 98,868 |
| Dividend | 3.83 | 4.00 | 4.16 | 4.44 | 4.28 |
| Dividend Yield (in %) | 2.40 % | 2.51 % | 2.61 % | 2.78 % | 2.68 % |
| EPS | 6.45 | 6.96 | 7.51 | 8.04 | 8.31 |
| P/E Ratio | 24.73 | 22.91 | 21.25 | 19.85 | 19.21 |
| EBIT | 20,171 | 21,473 | 23,024 | 24,003 | 25,149 |
| EBITDA | 22,855 | 24,452 | 26,216 | 27,658 | 29,598 |
| Net Profit | 15,846 | 16,960 | 18,081 | 18,741 | 19,675 |
| Net Profit Adjusted | 15,901 | 16,995 | 18,158 | 18,790 | - |
| Pre-Tax Profit | 20,085 | 21,477 | 22,947 | 23,947 | 25,270 |
| Net Profit (Adjusted) | 19,485 | 21,305 | 22,730 | 23,551 | 25,270 |
| EPS (Non-GAAP) ex. SOE | 6.45 | 6.96 | 7.51 | 8.04 | 8.31 |
| EPS (GAAP) | 6.18 | 6.89 | 7.48 | 7.85 | 8.34 |
| Gross Income | 42,906 | 44,764 | 46,656 | - | - |
| Cash Flow from Investing | -2,409 | -2,453 | -2,306 | -4,751 | - |
| Cash Flow from Operations | 19,094 | 20,543 | 22,095 | 23,506 | - |
| Cash Flow from Financing | -15,694 | -14,893 | -15,020 | -22,829 | - |
| Cash Flow per Share | 7.16 | 7.82 | 8.50 | 8.27 | 10.33 |
| Free Cash Flow | 15,490 | 16,538 | 17,653 | 19,017 | - |
| Free Cash Flow per Share | 6.37 | 6.70 | 7.15 | - | - |
| Book Value per Share | 21.51 | 23.58 | 23.78 | 24.25 | 26.38 |
| Net Debt | 26,634 | 24,961 | 22,113 | 19,889 | 11,743 |
| Research & Development Exp. | 2,293 | 2,382 | 2,741 | - | - |
| Capital Expenditure | 3,573 | 3,899 | 4,013 | 3,884 | 4,350 |
| Selling, General & Admin. Exp. | 23,190 | 23,574 | 24,228 | - | - |
| Shareholder’s Equity | 49,999 | 51,938 | 54,659 | 58,702 | 63,514 |
| Total Assets | 119,077 | 122,864 | 127,574 | 109,269 | - |
| Previous Quarter | Current Quarter | Next Quarter ending 06/30/24 | Current Year ending 06/30/24 | Next Year ending 06/30/25 | |
|---|---|---|---|---|---|
| Earnings Estimates | |||||
| No. of Analysts | - | - | 19 | 22 | 22 |
| Average Estimate | - | - | 1.379 USD | 6.454 USD | 6.965 USD |
| Year Ago | - | - | 1.370 USD | 5.900 USD | 6.454 USD |
| Publish Date | - | - | 1/23/2024 | - | - |
| Revenue Estimates | |||||
| No. of Analysts | - | - | 16 | 22 | 22 |
| Average Estimate | - | - | 20,985 USD | 84,814 USD | 88,057 USD |
| Year Ago | - | - | 20,553 USD | 82,006 USD | 84,814 USD |
| Publish Date | - | - | 1/23/2024 | - | - |
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet
Procter & Gamble Insider Activity
| Name | Date | shares traded | shares held | Price | type (sell/buy) | option |
|---|---|---|---|---|---|---|
| Keith R. Alexandra | 03/03/2024 | 776.00 | 4,858.55 | 158.11 | Sell | No |
| Whaley Susan Street | 02/22/2024 | 3,865.00 | 11,885.75 | 160.60 | Sell | No |
| Whaley Susan Street | 02/22/2024 | 3,865.00 | 15,750.75 | 139.24 | Buy | No |
| Jejurikar Shailesh | 02/20/2024 | 31,430.00 | 9,681.17 | 159.90 | Sell | No |
| Jejurikar Shailesh | 02/20/2024 | 31,430.00 | 41,111.17 | 91.07 | Buy | No |
| Coombe Gary A | 02/19/2024 | 22,000.00 | 36,845.25 | 158.98 | Sell | No |
| Coombe Gary A | 02/19/2024 | 22,000.00 | 58,845.25 | 80.29 | Buy | No |
| Francisco Ma. Fatima | 02/05/2024 | 25,000.00 | 973.19 | 159.00 | Sell | No |
| Francisco Ma. Fatima | 02/05/2024 | 25,000.00 | 25,973.19 | 78.52 | Buy | No |
| Francisco Ma. Fatima | 01/28/2024 | 45,000.00 | 973.19 | 156.00 | Sell | No |
| Francisco Ma. Fatima | 01/28/2024 | 45,000.00 | 45,973.19 | 78.52 | Buy | No |
| Jejurikar Shailesh | 01/24/2024 | 31,275.00 | 9,623.44 | 154.90 | Sell | No |
| Purushothaman Balaji | 01/24/2024 | 14,000.00 | 11,478.00 | 154.61 | Sell | No |
| Jejurikar Shailesh | 01/24/2024 | 31,275.00 | 40,898.44 | 80.29 | Buy | No |
| Purushothaman Balaji | 01/24/2024 | 14,000.00 | 25,478.00 | 80.29 | Buy | No |
| Pritchard Marc S. | 01/23/2024 | 101,704.00 | 163,428.39 | 153.57 | Sell | No |
| Francisco Ma. Fatima | 01/23/2024 | 10,154.00 | 973.19 | 153.91 | Sell | No |
| Francisco Ma. Fatima | 01/23/2024 | 64,289.00 | 973.19 | 153.20 | Sell | No |
| Pritchard Marc S. | 01/23/2024 | 101,704.00 | 265,132.39 | 78.66 | Buy | No |
| Francisco Ma. Fatima | 01/23/2024 | 64,289.00 | 65,262.19 | 91.07 | Buy | No |
| McEvoy Ashley | 12/11/2023 | 1,247.00 | 1,247.00 | n/a | Buy | No |
| JIMENEZ JOSEPH | 12/11/2023 | 326.00 | 30,015.99 | n/a | Buy | No |
| Kempczinski Christopher J | 12/11/2023 | 206.00 | 6,314.91 | n/a | Buy | No |
| LUNDGREN TERRY J | 12/11/2023 | 249.00 | 38,908.70 | n/a | Buy | No |
| Biggs M. Brett | 12/11/2023 | 185.00 | 1,714.45 | n/a | Buy | No |
Procter & Gamble Dividend Calendar
| Date | Name | Dividend | *yield | Currency |
|---|---|---|---|---|
| 2023 | Procter & Gamble Co. | 3.68 | 2.43 | USD |
| 2022 | Procter & Gamble Co. | 3.52 | 2.45 | USD |
| 2021 | Procter & Gamble Co. | 3.24 | 2.40 | USD |
| 2020 | Procter & Gamble Co. | 3.03 | 2.53 | USD |
| 2019 | Procter & Gamble Co. | 2.90 | 2.64 | USD |
| 2018 | Procter & Gamble Co. | 2.79 | 3.57 | USD |
| 2017 | Procter & Gamble Co. | 2.70 | 3.10 | USD |
| 2016 | Procter & Gamble Co. | 2.66 | 3.14 | USD |
| 2015 | Procter & Gamble Co. | 2.59 | 3.32 | USD |
| 2015 | Procter & Gamble Co. | 2.59 | 3.31 | USD |
| 2014 | Procter & Gamble Co. | 2.45 | 3.12 | USD |
| 2013 | Procter & Gamble Co. | 2.29 | 2.97 | USD |
| 2012 | Procter & Gamble Co. | 2.14 | 3.49 | USD |
| 2011 | Procter & Gamble Co. | 1.97 | 3.10 | USD |
| 2010 | Procter & Gamble Co. | 1.80 | 3.00 | USD |
| 2009 | Procter & Gamble Co. | 1.64 | 3.21 | USD |
| 2008 | Procter & Gamble Co. | 1.45 | 2.38 | USD |
| 2007 | Procter & Gamble Co. | 1.28 | 2.09 | USD |
| 2006 | Procter & Gamble Co. | 1.15 | 2.07 | USD |
| 2005 | Procter & Gamble Co. | 1.03 | 1.86 | USD |
| 2004 | Procter & Gamble Co. | 0.93 | 1.72 | USD |
| 2003 | Procter & Gamble Co. | 0.82 | 1.84 | USD |
| 2002 | Procter & Gamble Co. | 0.76 | 1.70 | USD |
| 2001 | Procter & Gamble Co. | 0.70 | 2.19 | USD |
| 2000 | Procter & Gamble Co. | 0.64 | 2.26 | USD |
| 1999 | Procter & Gamble Co. | 0.57 | 1.29 | USD |
*Yield of the Respective Date
Procter & Gamble Co. Calendar
| Event | Estimate | Info | Date |
|---|---|---|---|
| Earnings Report | - | Q3 2024 Earnings Release | 04/18/2024 |
| Earnings Report | - | Q4 2024 Earnings Release | 07/26/2024 |
| Earnings Report | - | Q1 2025 Earnings Release | 10/16/2024 |
| Earnings Report | - | Q2 2025 Earnings Release | 01/28/2025 |
| Earnings Report | - | Q3 2025 Earnings Release | 04/17/2025 |
Procter & Gamble Co. Past Events
| Event | Actual EPS | Info | Date |
|---|---|---|---|
| Earnings Report | 1.370 USD | Q2 2024 Earnings Release | 01/23/2024 |
| Press Conference | - | - | 07/28/2023 |
| Press Conference | - | - | 04/21/2023 |
Procter & Gamble Profile
Procter & Gamble Co. engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances. The Health Care segment includes oral care products like toothbrushes, toothpaste, and personal health care such as gastrointestinal, rapid diagnostics, respiratory, and vitamins, minerals, and supplements. The Fabric and Home care segment consists of fabric enhancers, laundry additives and detergents, and air, dish, and surface care. The Baby, Feminine and Family Care segment sells baby wipes, diapers, and pants, adult incontinence, feminine care, paper towels, tissues, and toilet paper.
Moody’s Daily Credit Risk Score
Risk
- Low
- Medium
- High
1
Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’sbalance sheet and inputs from the stock market. The score provides a forward-looking, one-year measure of creditrisk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes intoaccount day-to-day movements in market value compared to a company’s liability structure.
Procter & Gamble Shareholder
| Owner | in % |
|---|---|
| Freefloat | 99.94 |
| The Vanguard Group, Inc. | 9.56 |
| Vanguard Group, Inc. (Subfiler) | 9.12 |
| State Street Corp. | 4.38 |
| Vanguard Total Stock Market ETF | 3.15 |
| Vanguard 500 Index Fund | 2.48 |
| BlackRock Fund Advisors | 2.47 |
| BlackRock Institutional Trust Co. NA | 2.19 |
| Geode Capital Management LLC | 2.00 |
| Wellington Management Co. LLP | 1.46 |
| Fidelity 500 Index Fund | 1.19 |
| Norges Bank (13F) | 1.15 |
| Government Pension Fund - Global (The) | 1.12 |
| Morgan Stanley Smith Barney LLC | 0.87 |
| T Rowe Price Associates, Inc. (13F Subfiler) | 0.74 |
Shareholder percentage totals can add to more than 100% because some holders are included in the free float.
Procter & Gamble Management
| Name | Job |
|---|---|
| Jon R. Moeller | Chairman, President & Chief Executive Officer |
| Matthew W. Janzaruk | Chief Accounting Officer & Senior Vice President |
| Kirti Singh | Chief Analytics & Insights Officer |
| Marc S. Pritchard | Chief Brand Officer |
| Damon Jones | Chief Communications Officer |
| Philip J. Duncan | Chief Design Officer |
| Shelly McNamara | Chief Equality & Inclusion Officer |
| Ken K. Patel | Chief Ethics & Compliance Officer |
| Fatima Francisco | Chief Executive Officer-Baby & Feminine Care |
| R. Alexandra Keith | Chief Executive Officer-Beauty |
| Andre Schulten | Chief Financial Officer |
| Bala Purushothaman | Chief Human Resources Officer |
| Vittorio Cretella | Chief Information Officer |
| Shailesh G. Jejurikar | Chief Operating Officer |
| Luc Reynaert | Chief Product Supply Officer |
| Victor Aguilar | Chief Research, Development & Innovation Officer |
| Mindy Sherwood | Chief Sales Officer & President-Global Walmart |
| Virginie Helias | Chief Sustainability Officer |
| Brett M. Biggs | Director |
| Joe Stegbauer | General Counsel, SVP-Corporate & Global Business |
| Amy L. Chang | Independent Director |
| Terry J. Lundgren | Independent Director |
| Ashley A. McEvoy | Independent Director |
| Bertrand-Marc Allen | Independent Director |
| Debra L. Lee | Independent Director |
| Angela F. Braly | Independent Director |
| Rajesh Subramaniam | Independent Director |
| Robert Jones Portman | Independent Director |
| Christine M. McCarthy | Independent Director |
| Christopher J. Kempczinski | Independent Director |
| Sheila Bonini | Independent Director |
| Patricia Ann Woertz | Independent Director |
| John T. Chevalier | Investor Relations Contact |
| Joseph Jimenez | Lead Independent Director |
| Ivy Ross | Member-Design Board |
| Magesvaran Suranjan | President-Asia Pacific Selling & Market Operations |
| Monica Turner | President-North America |
| Gagan Sawhney | Regional CFO-Middle East & Africa |
| Sonali Dhawan | SVP-Marketing, Feminine Hygiene Asia, Middle East |
| Susan Street Whaley | Secretary & Chief Legal Officer |
| Namrata P Patel | Senior Vice President-Product Supply |
